Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any familial pancreatic carcinoma in which the cause of the disease is a mutation in the PALB2 gene.
Features include: Pancreatic adenocarcinoma.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 1 | Pancreatic adenocarcinoma |
Biomarker and diagnostic research for pancreatic cancer, susceptibility to, 3 has been reported in the published literature.
No clinical trials have been registered for pancreatic cancer, susceptibility to, 3.
93 publications have been identified in PubMed for pancreatic cancer, susceptibility to, 3. Research spans Review / Meta-Analysis (35%), Epidemiology / Natural History (27%), and Basic Science / Preclinical (25%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 33 | 35% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 3:32 PM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Claim this page and your organization will be listed here for patients and families to find.
Online Mendelian Inheritance in Man
Disease patterns and progression
25 |
27% |
Laboratory research | 23 | 25% |
Testing and diagnosis research | 5 | 5% |
Clinical study results | 5 | 5% |
New treatment approaches | 2 | 2% |
Hayashi H (2026). [PMID: 41876325](https://pubmed.ncbi.nlm.nih.gov/41876325/). *Pancreatology*. [Basic Science / Preclinical]
Zhang X (2026). [PMID: 40796306](https://pubmed.ncbi.nlm.nih.gov/40796306/). *J Mol Cell Biol*. [Basic Science / Preclinical]
Miura Y (2026). [PMID: 41085800](https://pubmed.ncbi.nlm.nih.gov/41085800/). *Ann Surg Oncol*. [Epidemiology / Natural History]
Whitworth J (2026). [PMID: 41926963](https://pubmed.ncbi.nlm.nih.gov/41926963/). *Lancet Oncol*. [Epidemiology / Natural History]
Tang R (2026). [PMID: 42209505](https://pubmed.ncbi.nlm.nih.gov/42209505/). *Nat Commun*. [Gene Therapy / Novel Therapeutics]
Kidogawa H (2026). [PMID: 42028523](https://pubmed.ncbi.nlm.nih.gov/42028523/). *Cureus*. [Review / Meta-Analysis]
Kinny-Köster B (2026). [PMID: 38967356](https://pubmed.ncbi.nlm.nih.gov/38967356/). *Ann Surg*. [Clinical Trial Publication]
Liu C (2026). [PMID: 41807033](https://pubmed.ncbi.nlm.nih.gov/41807033/). *J Immunother Cancer*. [Basic Science / Preclinical]
Fujiwara N (2026). [PMID: 40262132](https://pubmed.ncbi.nlm.nih.gov/40262132/). *Hepatology*. [Basic Science / Preclinical]
Martínez-Martínez FJ (2026). [PMID: 41453373](https://pubmed.ncbi.nlm.nih.gov/41453373/). *Lancet Microbe*. [Epidemiology / Natural History]